HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BRTX

BioRestorative Therapies Inc

Last Close
Dec 10 • 04:00PM ET
1.47
Dollar change
-0.02
Percentage change
-1.34 		%
Healthcare • Biotechnology • USA • NASD
Peers: BLUE AXSM FATE BLFS MESO CLPT STEM RCEL PRGO MNMD
 | Held by: VXF
Scroll to Statements
Index- P/E- EPS (ttm)-0.71 Insider Own26.61% Shs Outstand6.92M Perf Week-0.34%
Market Cap10.17M Forward P/E- EPS next Y-1.45 Insider Trans-0.06% Shs Float5.08M Perf Month-8.70%
Income-6.17M PEG- EPS next Q-0.34 Inst Own13.74% Short Float1.32% Perf Quarter-0.88%
Sales0.38M P/S26.76 EPS this Y58.87% Inst Trans- Short Ratio1.32 Perf Half Y25.64%
Book/sh1.44 P/B1.02 EPS next Y-3.08% ROA-43.49% Short Interest0.07M Perf Year-17.42%
Cash/sh1.89 P/C0.78 EPS next 5Y- ROE-54.09% 52W Range1.03 - 3.67 Perf YTD-15.51%
Dividend Est.- P/FCF- EPS past 5Y79.34% ROI-61.76% 52W High-59.94% Beta62.51
Dividend TTM- Quick Ratio2.94 Sales past 5Y23.65% Gross Margin45.32% 52W Low42.72% ATR (14)0.12
Dividend Ex-Date- Current Ratio2.94 EPS Y/Y TTM82.66% Oper. Margin-3205.76% RSI (14)44.64 Volatility9.37% 9.25%
Employees11 Debt/Eq0.00 Sales Y/Y TTM189.55% Profit Margin-1636.78% Recom1.00 Target Price13.67
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q79.00% Payout- Rel Volume0.24 Prev Close1.49
Sales Surprise-23.19% EPS Surprise70.00% Sales Q/Q660.91% EarningsNov 13 BMO Avg Volume50.61K Price1.47
SMA20-0.83% SMA50-6.00% SMA200-3.78% Trades Volume12,325 Change-1.34%
Dec-05-24 06:45AM
BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem Metabolic Disease Program
(GlobeNewswire)
Nov-13-24 07:00AM
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
(GlobeNewswire) -6.10%
Nov-12-24 04:05PM
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
(GlobeNewswire)
Nov-06-24 07:00AM
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
(GlobeNewswire) +6.45%
Nov-05-24 07:10AM
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
(GlobeNewswire)
07:00AM Loading…
Oct-31-24 07:00AM
BioRestorative Therapies Receives Patent Allowance for ThermoStem Metabolic Disease Program
(GlobeNewswire)
Oct-10-24 07:00AM
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events
(GlobeNewswire)
Oct-03-24 04:15PM
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
(GlobeNewswire)
Sep-19-24 06:55AM
BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
(GlobeNewswire)
Aug-13-24 05:55PM
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates
(Zacks)
04:05PM
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update
(GlobeNewswire)
Aug-06-24 04:05PM
BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024
(GlobeNewswire)
Jul-23-24 07:10AM
BioRestorative Therapies' Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine
(GlobeNewswire)
Jun-27-24 07:40AM
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem Metabolic Disease Program
(GlobeNewswire) -9.41%
Jun-17-24 07:05AM
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
(GlobeNewswire) +20.00%
07:00AM Loading…
Jun-13-24 07:00AM
BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem Metabolic Disease Program
(GlobeNewswire) +44.44%
Jun-12-24 08:52AM
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q1 2024
(InvestorPlace) +15.38%
Jun-11-24 05:50PM
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
(Zacks)
Jun-04-24 08:50AM
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
(GlobeNewswire) -5.43%
May-24-24 07:45PM
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
(GlobeNewswire)
May-15-24 09:00AM
BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market
(ACCESSWIRE)
May-14-24 04:10PM
BioRestorative Therapies Provides First Quarter 2024 Business Update
(GlobeNewswire)
May-08-24 07:30AM
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
(GlobeNewswire)
Apr-30-24 04:15PM
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
(GlobeNewswire) +14.52%
07:30AM
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
(GlobeNewswire)
Apr-16-24 07:45AM
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
(GlobeNewswire)
Apr-14-24 03:00PM
10 Micro-Cap Healthcare Stocks Insiders Are Buying
(Insider Monkey)
Apr-08-24 07:45AM
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
(GlobeNewswire)
Apr-03-24 04:38PM
BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants
(GlobeNewswire)
Apr-02-24 09:53AM
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q4 2023
(InvestorPlace)
07:45AM Loading…
Apr-01-24 07:45AM
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
(GlobeNewswire)
Mar-11-24 04:15PM
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
(GlobeNewswire)
Feb-14-24 09:15AM
BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting
(ACCESSWIRE)
Feb-06-24 08:05AM
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
(GlobeNewswire) -54.49%
Feb-05-24 07:30AM
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
(GlobeNewswire) +23.21%
Feb-01-24 07:30AM
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
(GlobeNewswire) +32.52%
Dec-12-23 09:15AM
BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program
(GlobeNewswire) +5.75%
Dec-03-23 01:11PM
11 Most Volatile Stocks Under $5 For Day Trading
(Insider Monkey)
Oct-09-23 12:10PM
BioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York City
(GlobeNewswire)
Oct-02-23 09:14AM
QIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software
(Zacks) +15.64%
Sep-18-23 09:00AM
Roth MKM Analyst Projects An Impressive Price Target of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says Low Valuation Undeserved
(ACCESSWIRE)
Sep-12-23 10:30AM
EXCLUSIVE: Stem Cell Focused BioRestorative Ventures Into $63B Aesthetics Market Via Supply Agreement With Evolutionary Biologics
(Benzinga) -12.37%
09:00AM
BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics
(GlobeNewswire)
Sep-08-23 08:30AM
BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
(GlobeNewswire) -5.40%
Aug-30-23 09:00AM
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
(ACCESSWIRE)
Aug-08-23 06:05PM
Mirati (MRTX) Reports Q2 Loss, Misses Revenue Estimates
(Zacks)
Aug-02-23 09:00AM
BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares
(ACCESSWIRE)
Jul-31-23 08:05AM
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform - Insights From The Discussion
(ACCESSWIRE)
Jul-26-23 01:01PM
Insider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX)
(GuruFocus.com) +11.73%
Jul-21-23 07:10AM
BioRestorative Therapies (NASDAQ:BRTX) Receives Landmark License From New York State
(ACCESSWIRE) -5.32%
Jul-11-23 08:30AM
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
(GlobeNewswire) -13.20%
Jul-07-23 07:00AM
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
(ACCESSWIRE) -7.26%
Jun-27-23 08:30AM
EXCLUSIVE: Data Monitoring Committee Allows BioRestorative's Chronic Lumbar Disc Disease Study To Continue Unchanged
(Benzinga) -23.88%
07:00AM
BioRestorative Therapies Receives Unanimous Recommendation from Data Safety Monitoring Board (DSMB) to Continue its Phase 2 Clinical Trial without any Changes
(GlobeNewswire)
Jun-26-23 07:30AM
BioResorative CEO is Featured in An Interview With SmallCaps Daily
(NewMediaWire) +13.46%
Jun-17-23 08:36AM
Is BioRestorative Therapies (NASDAQ:BRTX) In A Good Position To Invest In Growth?
(Simply Wall St.)
Jun-16-23 07:00AM
BioRestorative Therapies, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
(GlobeNewswire) +9.65%
Jun-15-23 07:48AM
Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It
(ACCESSWIRE)
Jun-12-23 08:31AM
EXCLUSIVE: BioRestorative Completes Dosing In Safety Cohort Of Chronic Lower Back Pain Trial
(Benzinga)
07:00AM
BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease
(GlobeNewswire)
Jun-01-23 09:15AM
BioRestorative Therapies, Inc. to attend the Jefferies 2023 Healthcare Conference
(GlobeNewswire)
May-31-23 08:30AM
EXCLUSIVE: BioRestorative Therapies Wins License from New York State Department of Health To Act As Tissue Bank for Mesenchymal Stem Cell Processing
(Benzinga) -9.09%
07:00AM
BioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell Processing
(GlobeNewswire)
May-15-23 08:31AM
EXCLUSIVE: BioRestorative Therapies' ThermoStem For Metabolic Disorders Expected To Receive Fourth Japanese Patent
(Benzinga) +5.40%
07:00AM
BioRestorative Therapies Receives Notice of Allowance by the Japanese Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program
(GlobeNewswire)
May-12-23 07:15AM
A New Era In Regenerative Medicine? BioRestorative Therapies (NASDAQ:BRTX) Reports Leading The Expansion Of The Adipose-Derived Stem Cell Therapy Market
(ACCESSWIRE)
May-08-23 07:00AM
BioRestorative Therapies and Northwell Health Enter into Agreement to Participate in the Companys Phase 2 Clinical Trial
(GlobeNewswire) +17.95%
May-04-23 07:00AM
BioRestorative Therapies, Inc. to participate at the EF Hutton Global Conference May 10-11 in New York City
(GlobeNewswire)
Apr-24-23 08:30AM
EXCLUSIVE: BioRestorative Concludes Enrollment For Safety Run-In Component Of Cell Therapy Study For Chronic Lower Back Pain
(Benzinga)
07:00AM
BioRestorative Therapies Announces Completion of Patient Enrollment for Safety Run-In Component of its Phase 2 Clinical Study of BRTX-100
(GlobeNewswire)
Mar-31-23 08:30AM
BioRestorative Therapies (NASDAQ: BRTX) Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion
(News Direct)
Mar-28-23 07:01AM
Bullish BioRestorative Therapies, Inc. (NASDAQ:BRTX) insiders filled their treasuries with US$593k worth of stock over last year
(Simply Wall St.)
Mar-22-23 09:15AM
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
(News Direct)
Mar-13-23 08:30AM
EXCLUSIVE: BioRestorative Seeks Expanded FDA Approval For BRTX-100 Clinical Application, Engages Advisory Firm
(Benzinga)
07:00AM
BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100
(GlobeNewswire)
Mar-09-23 06:30AM
BRTXs ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
(News Direct)
Mar-07-23 06:30AM
BioRestorative Therapies to Participate at the 35th Annual ROTH MKM Conference on March 12 -14, 2023
(GlobeNewswire) -9.80%
Mar-02-23 09:00AM
EXCLUSIVE: BioRestorative To Receive Third US Patent For Metabolic ThermoStem Program
(Benzinga) +29.39%
07:30AM
BioRestorative Therapies Receives Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program
(GlobeNewswire)
Feb-10-23 08:45AM
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
(News Direct)
Feb-08-23 09:00AM
BioRestorative Therapies Announces Notice of Allowance by the European Patent Office for Patent Related to its ThermoStem® Program
(GlobeNewswire)
08:30AM
EXCLUSIVE: BioRestorative Poised To Receive European Patent For ThermoStem Program
(Benzinga)
Feb-03-23 09:25AM
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
(News Direct)
Jan-26-23 08:30AM
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
(News Direct)
Jan-17-23 09:29AM
BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event
(Newsfile) -9.79%
Dec-06-22 07:00AM
BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication
(GlobeNewswire) -6.61%
06:31AM
EXCLUSIVE: BioRestorative Secures Funding Support For Programs Against Polycystic Ovary Syndrome
(Benzinga)
Dec-05-22 07:00AM
BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease
(GlobeNewswire) -5.33%
06:30AM
EXCLUSIVE: BioRestorative Therapies Gets Exclusive License Rights From Regenexx For Development Of BRTX-100 Disc Program To Treat Chronic Lumbar Disc Disease
(Benzinga)
Nov-29-22 11:20AM
BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022
(GlobeNewswire) +5.49%
Nov-16-22 08:56AM
BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
(GlobeNewswire)
05:16AM
BioRestorative Therapies Third Quarter 2022 Earnings: US$1.28 loss per share (vs US$4.99 loss in 3Q 2021)
(Simply Wall St.)
Nov-10-22 08:00AM
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
(News Direct) +8.77%
Oct-31-22 08:15AM
See Whats Next For The Regenerative Medicine Field -- BioRestorative Intends to Lead The Pack In Stem Cell Therapies!
(News Direct) -5.03%
Oct-20-22 09:30AM
BioRestorative Therapies CEO Lance Alstodt to be Interviewed on Famela and Friends Talk Radio Show
(GlobeNewswire)
Oct-14-22 08:00AM
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
(News Direct)
Sep-28-22 07:00AM
BioRestorative Therapies to Present at the Dawson James Securities 7th Annual Small Cap Growth Conference
(GlobeNewswire) +15.04%
Sep-27-22 07:00AM
BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference
(GlobeNewswire)
Sep-07-22 07:00AM
BioRestorative Therapies to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14
(GlobeNewswire)
Sep-01-22 09:00AM
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
(News Direct)
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadrick Dale10% OwnerOct 28 '24Sale1.581,1121,757445,933Nov 05 04:33 PM
Silva FranciscoVP of Research and DevelopmentApr 09 '24Buy1.256,6008,250155,759Apr 10 05:16 PM
Silva FranciscoVP of Research and DevelopmentApr 08 '24Buy1.161,7081,979149,159Apr 10 05:16 PM
Broadrick Dale10% OwnerFeb 09 '24Buy1.3286,041113,574477,972Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.2573,95992,449391,931Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.3483,626112,059447,045Feb 09 08:00 AM
Broadrick Dale10% OwnerFeb 07 '24Buy1.3836,37450,196363,419Feb 09 08:00 AM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.